Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 58.90%940.48K | 33.16%866.53K | -5.69%581.21K | -32.74%2.43M | -22.40%554.47K | -19.74%591.86K | -56.28%650.77K | -7.37%616.28K | 65.45%3.61M | 39.12%714.55K |
| Selling and administrative expenses | 2.04%326.23K | 15.72%347.38K | -14.36%302.49K | -47.95%1.26M | -27.44%284.19K | -19.55%319.71K | -75.17%300.2K | -15.31%353.21K | 76.97%2.42M | 14.22%391.68K |
| -Selling and marketing expense | 2,830.28%49.93K | 434.22%58.51K | -35.53%6.36K | -102.13%-3.69K | -94.77%2.24K | -94.97%1.7K | -131.40%-17.51K | -75.96%9.87K | 200.63%173.56K | 235.22%42.84K |
| -General and administrative expense | -13.12%276.3K | -9.07%288.88K | -13.75%296.12K | -43.75%1.26M | -19.17%281.95K | -12.52%318.01K | -72.46%317.71K | -8.69%343.34K | 71.51%2.24M | 5.66%348.84K |
| Research and development costs | 164.24%498.75K | 77.03%439.57K | 18.08%218.04K | -6.06%852.39K | -18.28%230.69K | -30.00%188.75K | 34.35%248.31K | 8.19%184.65K | 63.29%907.43K | 130.26%282.31K |
| Depreciation amortization depletion | -46.81%33.27K | 2.22%33.27K | 2.22%33.27K | 14.18%134.3K | -115.61%-5.51K | 108.69%62.55K | 24.22%32.55K | 24.35%32.55K | 15.08%117.62K | 29.64%35.28K |
| -Depreciation and amortization | -46.81%33.27K | 2.22%33.27K | 2.22%33.27K | 14.18%134.3K | -115.61%-5.51K | 108.69%62.55K | 24.22%32.55K | 24.35%32.55K | 15.08%117.62K | 29.64%35.28K |
| Other operating expenses | 294.20%82.23K | -33.57%46.31K | -40.22%27.42K | 9.66%181.54K | 752.21%45.1K | -48.41%20.86K | 1.93%69.71K | -10.80%45.87K | 5.67%165.54K | -74.66%5.29K |
| Operating profit | -58.90%-940.48K | -33.16%-866.53K | 5.69%-581.21K | 32.74%-2.43M | 22.40%-554.47K | 19.74%-591.86K | 56.28%-650.77K | 7.37%-616.28K | -65.45%-3.61M | -39.12%-714.55K |
| Net non-operating interest income (expenses) | -109.31%-350.73K | -246.76%-340.78K | -3,577.90%-285.07K | -1,932.32%-595.43K | -3,623.33%-334.02K | -2,625.88%-167.56K | -1,262.48%-98.28K | -11.25%-7.75K | -10.02%-29.3K | 66.31%-8.97K |
| Non-operating interest income | -99.98%4 | ---- | --9.71K | --43.63K | 1,222.33%14.83K | 1,575.85%22.14K | --6.66K | --0 | --0 | ---1.32K |
| Non-operating interest expense | 84.89%350.73K | 224.75%340.78K | 3,703.15%294.78K | 2,081.22%639.06K | 4,460.08%348.85K | 2,440.14%189.7K | 1,354.83%104.94K | 11.25%7.75K | 10.02%29.3K | -71.27%7.65K |
| Other net income (expenses) | -193.90%-10.61K | 133.90%6.51K | -104.17%-14.34K | -356.25%-38.18K | -311.47%-8.34K | 37.46%-3.61K | -511.26%-19.21K | -106.74%-7.02K | 39.68%-8.37K | 252.55%3.94K |
| Gain on sale of security | -193.90%-10.61K | 133.90%6.51K | -104.17%-14.34K | -356.25%-38.18K | -311.47%-8.34K | 37.46%-3.61K | -511.26%-19.21K | -106.74%-7.02K | 39.68%-8.37K | 252.55%3.94K |
| Income before tax | -70.61%-1.3M | -56.30%-1.2M | -39.55%-880.62K | 16.04%-3.06M | -24.63%-896.83K | -1.82%-763.03K | 48.75%-768.26K | 6.61%-631.05K | -64.13%-3.64M | -32.56%-719.58K |
| Income tax | -37K | 0 | ||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -70.61%-1.3M | -56.30%-1.2M | -39.55%-880.62K | 17.06%-3.02M | -19.49%-859.83K | -1.82%-763.03K | 48.75%-768.26K | 6.61%-631.05K | -64.13%-3.64M | -32.56%-719.58K |
| Net income continuous operations | -70.61%-1.3M | -56.30%-1.2M | -39.55%-880.62K | 17.06%-3.02M | -19.49%-859.83K | -1.82%-763.03K | 48.75%-768.26K | 6.61%-631.05K | -64.13%-3.64M | -32.56%-719.58K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -70.61%-1.3M | -56.30%-1.2M | -39.55%-880.62K | 17.06%-3.02M | -19.49%-859.83K | -1.82%-763.03K | 48.75%-768.26K | 6.61%-631.05K | -64.13%-3.64M | -32.56%-719.58K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -70.61%-1.3M | -56.30%-1.2M | -39.55%-880.62K | 17.06%-3.02M | -19.49%-859.83K | -1.82%-763.03K | 48.75%-768.26K | 6.61%-631.05K | -64.13%-3.64M | -32.56%-719.58K |
| Diluted earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.03 | -0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | -50.00%-0.03 | 0 |
| Basic earnings per share | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.03 | -0.01 | 0.00%-0.01 | 0.00%-0.01 | 0.00%-0.01 | -50.00%-0.03 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.